Kaveri Pohlman
Stock Analyst at BTIG
(0.26)
# 4,098
Out of 4,761 analysts
21
Total ratings
15%
Success rate
-27.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGNX MacroGenics | Downgrades: Neutral | n/a | $2.76 | - | 4 | Aug 1, 2024 | |
| GMAB Genmab | Maintains: Buy | $46 → $47 | $22.34 | +110.38% | 3 | Jun 27, 2024 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $20 → $30 | $9.03 | +232.23% | 2 | Apr 17, 2024 | |
| XNCR Xencor | Maintains: Buy | $56 → $38 | $15.74 | +141.42% | 1 | Apr 16, 2024 | |
| NUVB Nuvation Bio | Upgrades: Buy | $5 | $2.21 | +126.24% | 2 | Mar 26, 2024 | |
| JANX Janux Therapeutics | Initiates: Buy | $62 | $36.01 | +72.17% | 1 | Mar 21, 2024 | |
| PYXS Pyxis Oncology | Initiates: Buy | $8 | $1.28 | +525.00% | 1 | Feb 9, 2024 | |
| EXEL Exelixis | Initiates: Buy | $27 | $36.85 | -26.73% | 1 | Dec 19, 2023 | |
| RCUS Arcus Biosciences | Reiterates: Buy | $70 | $11.07 | +532.34% | 1 | Aug 23, 2023 | |
| STTK Shattuck Labs | Initiates: Buy | $12 | $1.37 | +775.91% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $0.78 | +925.64% | 2 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12,320 → $4,928 | $1.44 | +342,122.22% | 2 | Feb 9, 2022 |
MacroGenics
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.76
Upside: -
Genmab
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $22.34
Upside: +110.38%
Cullinan Therapeutics
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $9.03
Upside: +232.23%
Xencor
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $15.74
Upside: +141.42%
Nuvation Bio
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $2.21
Upside: +126.24%
Janux Therapeutics
Mar 21, 2024
Initiates: Buy
Price Target: $62
Current: $36.01
Upside: +72.17%
Pyxis Oncology
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $1.28
Upside: +525.00%
Exelixis
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $36.85
Upside: -26.73%
Arcus Biosciences
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $11.07
Upside: +532.34%
Shattuck Labs
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $1.37
Upside: +775.91%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $0.78
Upside: +925.64%
Feb 9, 2022
Maintains: Buy
Price Target: $12,320 → $4,928
Current: $1.44
Upside: +342,122.22%